Mu‐He Chen

A Tumor-pH-Responsive Supramolecular Photosensitizer for Activatable Photodynamic Therapy with Minimal In Vivo Skin Phototoxicity

Clinical development and potential of photothermal and photodynamic therapies for cancer

Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents

Nanotechnology for Multimodal Synergistic Cancer Therapy

Iridium Tungstate Nanozyme-Mediated Hypoxic Regulation and Anti-inflammation for Duplex Imaging Guided Photothermal Therapy of Metastatic Breast Tumors

The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials

A Luminescent Poly(amidoamine)–Iridium Complex as a New Singlet-Oxygen Sensitizer for Photodynamic Therapy

Nanocomposite‐Based Photodynamic Therapy Strategies for Deep Tumor Treatment

New photosensitizers for photodynamic therapy

Cancer‐Associated, Stimuli‐Driven, Turn on Theranostics for Multimodality Imaging and Therapy

Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy

Photothermal Nanomaterials: A Powerful Light-to-Heat Converter

Cyclometalated Ir(iii) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy

Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents

Dual Functions of Cyclometalated Iridium(III) Complexes: Anti-Metastasis and Lysosome-Damaged Photodynamic Therapy